Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...

A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater ...

The following is a summary of “Visual coronary artery calcification score to predict significant coronary artery stenosis in ...

Individuals who present with acute myocardial infarction in the absence of standard modifiable cardiovascular risk factors (ie, SMuRF‐less) seem to have a significantly increased risk of mortality; ...

Figure 10 shows Baylor polar maps of stress and rest studies for a patient with myocardial infarction affecting all regions except the septal wall. It shows a large island of reversible ischemia in a ...

Sotagliflozin, a dual SGLT1/2 inhibitor, shows benefit specifically for reducing myocardial infarction and stroke risks. Among patients with type 2 diabetes and chronic kidney disease (CKD) at ...

Department of Cardiovascular Medicine, The First Hospital of HeBei Medical University, Shijiazhuang 050031, Hebei Province, China Hebei Provincial Key Laboratory of Cardiac Injury Repair Mechanism ...

The results ... Classical symptoms of acute myocardial infarction include sudden chest pain (typically radiating to the left arm or left side of the neck), shortness of breath, nausea, vomiting ...